Cardiol Therapeutics Inc. (CRDL)

Cardiol Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	34.93	59.47	83.9	14.03	6.96
Cash & Cash Equivalents	34.93	59.47	83.9	14.03	6.96
Cash Growth	-41.26%	-29.12%	498.20%	101.62%	-
Receivables	0.28	0.48	0.41	0.22	0.93
Inventory	0	0	0	0.36	6.2
Other Current Assets	0.94	1.49	2.83	0.35	0.28
Total Current Assets	36.15	61.44	87.14	14.95	14.37
Property, Plant & Equipment	0.34	0.3	0.36	0.48	0.58
Goodwill and Intangibles	0.21	0.29	0.38	0.46	0.55
Total Long-Term Assets	0.55	0.59	0.74	0.94	1.13
Total Assets	36.7	62.03	87.88	15.89	15.5
Accounts Payable	8.04	9.33	4.86	2.47	0.64
Current Debt	0.02	0.05	0.04	0.05	0.05
Other Current Liabilities	0.24	0.42	6.66	0	0
Total Current Liabilities	8.3	9.8	11.57	2.52	0.69
Long-Term Debt	0.16	0.02	0.07	0.1	0.14
Total Long-Term Liabilities	0.16	0.02	0.07	0.1	0.14
Total Liabilities	8.45	9.83	11.64	2.62	0.83
Total Debt	0.17	0.07	0.12	0.16	0.19
Debt Growth	139.24%	-38.02%	-24.90%	-17.92%	-
Retained Earnings	-142.58	-114.45	-83.52	-51.88	-31.24
Shareholders' Equity	28.25	52.2	76.24	13.27	14.67
Net Cash / Debt	34.76	59.4	83.78	13.87	6.77
Net Cash / Debt Growth	-41.48%	-29.10%	504.11%	104.99%	-
Net Cash Per Share	0.54	0.95	1.94	0.46	0.26
Working Capital	27.86	51.63	75.58	12.43	13.68
Book Value Per Share	0.44	0.83	1.76	0.44	0.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).